| # | Title | Journal | Year | Citations |
|---|
| 1 | A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma | Cancer Treatment Reviews | 2009 | 185 |
| 2 | Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer | The Cochrane Library | 2006 | 146 |
| 3 | GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial | Annals of Oncology | 2017 | 119 |
| 4 | A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK | British Journal of Cancer | 2013 | 92 |
| 5 | Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial | Lancet Oncology, The | 2017 | 58 |
| 6 | Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide | Orphanet Journal of Rare Diseases | 2017 | 57 |
| 7 | Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen | Annals of Oncology | 2010 | 34 |
| 8 | Tako-Tsubo Syndrome after Trastuzumab — An Unusual Complication of Chemotherapy for Breast Cancer | Clinical Oncology | 2013 | 25 |
| 9 | Angiosarcoma of the head and neck | Journal of Laryngology and Otology | 1997 | 17 |
| 10 | Development of a Purification Procedure for the Isolation of Nucleosides from Urine Prior to Mass Spectrometric Analysis | Nucleosides, Nucleotides and Nucleic Acids | 2000 | 17 |
| 11 | Optimal sequence of hormonotherapy in advanced breast cancer | Current Opinion in Oncology | 2006 | 15 |
| 12 | Radiotherapy in the Management of Paediatric Low-Grade Gliomas | Clinical Oncology | 2019 | 13 |
| 13 | A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma | Medical Oncology | 2013 | 10 |
| 14 | Real-world use of bevacizumab in metastatic colorectal, metastatic breast, advanced ovarian and cervical cancer: a systematic literature review | Future Oncology | 2019 | 10 |
| 15 | UK Guidance Document: Treatment of Metastatic Breast Cancer | Clinical Oncology | 2012 | 8 |
| 16 | Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? | British Journal of Cancer | 2002 | 5 |
| 17 | Bevacizumab for Ovarian Cancer at High Risk of Progression: Reproducibility of Trial Results in ‘Real-world’ Patients | Anticancer Research | 2016 | 5 |
| 18 | Decision-making tools to assist prognosis and treatment choices in early breast cancer: a review | Expert Review of Anticancer Therapy | 2012 | 4 |
| 19 | A prospective randomised study of transvaginal ultrasound effects of tamoxifen and exemestane in postmenopausal women with early breast cancer | Tumori | 2014 | 3 |
| 20 | Management of advanced ovarian cancer in South West Wales − a comparison between primary debulking surgery and primary chemotherapy treatment strategies in an unselected, consecutive patient cohort | Cancer Epidemiology | 2017 | 2 |
| 21 | Reply to the letter to the editor ‘Measured and estimated glomerular filtration rate for carboplatin dose calculation’ by Cathomas et al. | Annals of Oncology | 2015 | 1 |
| 22 | PWE-330 Causes for delay in commencing adjuvant chemotherapy in rectal cancer | Gut | 2015 | 0 |
| 23 | PWE-329 A potential role of braf mutation immunohistochemistry in the investigation and treatment of anal melanoma | Gut | 2015 | 0 |
| 24 | Targeted molecular therapy: the cancer paradigm | | 2020 | 0 |
